Adage Capital Partners’s Cidara Therapeutics CDTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $53.6M | Buy |
1,100,000
+110,000
| +11% | +$5.36M | 0.09% | 222 |
|
|
2025
Q1 | $21.3M | Buy |
990,000
+620,046
| +168% | +$13.4M | 0.04% | 396 |
|
|
2024
Q4 | $9.94M | Buy |
369,954
+327,199
| +765% | +$8.8M | 0.02% | 611 |
|
|
2024
Q3 | $460K | Buy |
+42,755
| New | +$460K | ﹤0.01% | 816 |
|
|
2018
Q2 | – | Sell |
-17,800
| Closed | -$1.42M | – | 741 |
|
|
2018
Q1 | $1.42M | Buy |
+17,800
| New | +$1.42M | ﹤0.01% | 680 |
|